Burgeon Pharmaceuticals Private Limited, a active private limited company, was established on 08 May 1995 in Chennai-16., Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN1995PTC031280. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a active non-compliant status. Its leadership includes Parimaladevi Manimaran (Additional Director), Kanniah Manimaaran (Managing Director). Past directors included Pillaya Raja Ramaraj, Balasubramaniyam Jeyachandran, Vaitheeswaran Pachamuthu Aariappa. It holds ₹3.66 M open charges and ₹18.73 Cr settled loans. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at No 19No19,Rajastreet,Alandur, Chennai-16., Chennai-16., Tamil Nadu, 600016.
U24231TN1995PTC031280
031280
08 May 1995
₹6.00 Cr
₹2.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Burgeon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parimaladevi Manimaran | Additional Director | 18 Apr 2011 | Current |
| Kanniah Manimaaran | Managing Director | 26 Sep 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 14 Oct 2011 | Past |
| Pramod Abcsdd | Director | 24 Jun 2011 | Past |
| Pramod Abcsdd | Director | 02 Feb 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Burgeon Pharmaceuticals Private Limited, for the financial year ended 2014, experienced significant reduction in revenue, with a 86.48% decrease. The company also saw a substantial fall in profitability, with a 88.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 72.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2015, Burgeon Pharmaceuticals had a promoter holding of 59.79% and a public holding of 40.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,660,000.00
₹187,330,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Mar 2005 | Karur Vysya Bank | ₹2.50 M | Open |
| 25 Feb 2003 | The Karur Vysya Bank Ltd. | ₹0.58 M | Open |
| 25 Feb 2003 | The Krur Vysya Bank Ltd | ₹0.58 M | Open |
| 24 Oct 2005 | Indian Overseas Bank | ₹18.73 Cr | Satisfied |
Explore comprehensive loan charge details -
Burgeon Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Burgeon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Burgeon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Burgeon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was completed.
Progress on Burgeon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Chennai. was documented.
A charge registered on 24 Oct 2005 via Charge ID 90290888 with Indian Overseas Bank was fully satisfied on 25 Mar 2014. was recorded as a recent event.
Parimaladevi Manimaran was appointed as a Additional Director was appointed as a Additional Director on 18 Apr 2011 & has been associated with this company since 14 years 7 months . was recorded as a recent event.
Progress on A charge with Indian Overseas Bank of Rs. 18.73 Cr registered on 24 Oct 2005 with Charge ID 90290888 was modified on 13 Oct 2010. was documented.
A charge with Indian Overseas Bank amounted to Rs. 18.73 Cr with Charge ID 90290888 was registered on 24 Oct 2005. was recorded as a recent event.
The CIN of Burgeon Pharmaceuticals Private Limited is U24231TN1995PTC031280.
Burgeon Pharmaceuticals Private Limited is headquartered at No 19No19,Rajastreet,Alandur, Chennai-16., Chennai-16., Tamil Nadu, 600016.
Burgeon Pharmaceuticals Private Limited was incorporated on 08 May 1995.
The current directors of Burgeon Pharmaceuticals Private Limited are
The primary industry of Burgeon Pharmaceuticals Private Limited is Manufacturing.
Burgeon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Burgeon Pharmaceuticals Private Limited is ₹6.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Burgeon Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX